| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025349 |
| Receipt No. | R000029179 |
| Official scientific title of the study | Evaluation of the safety of a functional food containing lactic acid bacteria in healthy adults |
| Date of disclosure of the study information | 2018/03/14 |
| Last modified on | 2017/07/11 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Evaluation of the safety of a functional food containing lactic acid bacteria in healthy adults | |
| Title of the study (Brief title) | Evaluation of the safety of a functional food containing lactic acid bacteria | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | In order to investigate the safety of a 12-week consumption of food containing lactic acid bacteria |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The incidence of side effects during intervention |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intervention
Test beverages (containing lactic acid bacteria) Duration: 12 weeks |
|
| Interventions/Control_2 | Control
Negative control beverages Duration: 12 weeks |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Japanese untreated males and females from 20 to 69 years of age.
(2) Individuals who are judged as suitable for the study based on the results of preliminary clinical and physical examination. (3) Individuals who can have an examination in a designated day (4) Individuals who gave the written informed consent before the study. |
|||
| Key exclusion criteria | (1) Individuals who have hepatic disorders, renal and/or heart failure, organ damages, and/or other severe disorders.
(2) A surgical history of digestive system (except appendicectomy) (3) Individuals who undergo medical treatment for chronic diseases. (4) Individuals who are pregnant or have possibility to become pregnant during the study or breast-feeding. (5) Individuals who drink alcohol a lot. (6) Individuals who have tendency to get diarrhea by consuming milk or lactic acid bacteria. (7) With allergy to milk and/or soybean. (8) Individuals judged as unsuitable for the study by the principal investigator for other reasons. |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuhiko Takano |
| Organization | Medical Corporation Hokubukai |
| Division name | Utsukushigaoka Hospital |
| Address | 61-1 Sin-ei, Kiyota-ku, Sapporo, Hokkaido 004-0839, Japan |
| TEL | 001-882-0111 |
| info@csc-smo.co.jp | |
| Public contact | |
| Name of contact person | Isao Takehara |
| Organization | Clinical Support Corporation |
| Division name | PI-Food Service Division |
| Address | 4-1 South 1 West 8, Chuo-ku, Sapporo, Hokkaido 060-0061, Japan |
| TEL | 011-223-3130 |
| Homepage URL | |
| takehara@csc-smo.co.jp | |
| Sponsor | |
| Institute | Asahi Group Holdings, Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Asahi Group Holdings, Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029179 |